Hepatitis C virus (HCV) vertical transmission in 12-month-old infants born to HCV-infected women and assessment of maternal risk factors

Open Forum Infectious Diseases

Volumn 2, Issue 2, 2015, Pages

  Jhaveri, Ravi ^a   Hashem, Mohamed ^b   El Kamary, Samer S ^b   Saleh, Doa'a A ^c   Sharaf, Sahar A ^c   El Mougy, Fatma ^c   Abdelsalam, Lobna ^c   Ehab, Mohamed ^c   El Ghazaly, Hesham ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Egypt; Hepatitis C virus; Infants; Vertical transmission; Viral load

Indexed keywords

INTERLEUKIN 28; INTERLEUKIN 28B; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; COHORT ANALYSIS; DELIVERY; ENZYME IMMUNOASSAY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; VERTICAL TRANSMISSION;

EID: 84978328536     PISSN: None     EISSN: 23288957     Source Type: Journal    
DOI: 10.1093/ofid/ofv089     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention. Hepatitis C FAQs for Health Professionals. Available at: http://www.cdc.gov/hepatitis/HCV/HCVfaq.htm#section1. Accessed 20 November 2013.
2. El-Kamary SS, Jhaveri R, Shardell MD. All-cause, liver-related, and non-liver-related mortality among HCV-infected individuals in the general US population. Clin Infect Dis 2011; 53:150-7.
3. Jhaveri R, Grant W, Kauf TL, et al. The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period. J Pediatr 2006; 148:353-8.
4. Benova L, Awad SF, Miller FD, et al. Estimation of hepatitis C virus infections resulting from vertical transmission in Egypt. Hepatology 2015; 61:834-42.
5. Breban R, Doss W, Esmat G, et al. Towards realistic estimates of HCV incidence in Egypt. J Viral Hepat 2013; 20:294-6.
6. Lehman EM, Wilson ML. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality. J Viral Hepat 2009; 16:650-8.
7. Miller FD, Abu-Raddad LJ. Evidence of intense ongoing endemic transmission of hepatitis C virus in Egypt. Proc Natl Acad Sci U S A 2010; 107:14757-62.
8. Guerra J, Garenne M, Mohamed MK, et al. HCV burden of infection in Egypt: results from a nationwide survey. J Viral Hepat 2012; 19:560-7.
9. Denniston MM, Jiles RB, Drobeniuc J, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014; 160:293-300.
10. Arshad M, El-Kamary SS, Jhaveri R. Hepatitis C virus infection during pregnancy and the newborn period-are they opportunities for treatment? J Viral Hepat 2011; 18:229-36.
11. Ceci O, Margiotta M, Marello F, et al. Vertical transmission of hepatitis C virus in a cohort of 2, 447 HIV-seronegative pregnant women: a 24-month prospective study. J Pediatr Gastroenterol Nutr 2001; 33:570-5.
12. Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis 2005; 192:1880-9.
13. Shebl FM, El-Kamary SS, Saleh DA, et al. Prospective cohort study of mother-to-infant infection and clearance of hepatitis C in rural Egyptian villages. J Med Virol 2009; 81:1024-31.
14. Taylor N, Haschke-Becher E, Greil R, et al. Performance characteristics of the COBAS Ampliprep/COBAS TaqMan v2.0 and the Abbott Real-Time hepatitis C assays-implications for response-guided therapy in genotype 1 infections. Antivir Ther 2014; 19:449-54.
15. Germer JJ, Heimgartner PJ, Ilstrup DM, et al. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 assays for quantification of hepatitis C virus RNA in serum. J Clin Microbiol 2002; 40: 495-500.
16. Prasad MR, Honegger JR. Hepatitis C virus in pregnancy. Am J Perinatol 2013; 30:149-59.
17. Marine-Barjoan E, Berrebi A, Giordanengo V, et al. HCV/HIV coinfection, HCV viral load and mode of delivery: risk factors for mother-to-child transmission of hepatitis C virus? AIDS 2007; 21: 1811-5.
18. European Paediatric Hepatitis C Virus Network. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of hepatitis C virus. BJOG 2001; 108:371-7.
19. McMenamin MB, Jackson AD, Lambert J, et al. Obstetric management of hepatitis C-positive mothers: analysis of vertical transmission in 559 mother-infant pairs. Am J Obstet Gynecol 2008; 199:315.e1-5.
20. Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995; 14:195-9.
21. Resti M, Azzari C, Mannelli F, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 317:437-41.
22. Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 1998; 177:1480-8.
23. Checa Cabot CA, Stoszek SK, Quarleri J, et al. Mother-to-child transmission of hepatitis C virus (HCV) among HIV/HCV-coinfected women. J Pediatric Infect Dis Soc 2013; 2:126-35.
24. Ge D, Fellay J, Thompson AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature 2009; 461: 399-401.
25. Ruiz-Extremera A, Munoz-Gamez JA, Salmeron-Ruiz MA, et al. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology 2011; 53:1830-8.
26. Thomas DL, Thio CL, Martin MP, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009; 461: 798-801.
27. El-Kamary SS, Hashem M, Saleh DA, et al. Reliability of risk-based screening for hepatitis C virus infection among pregnant women in Egypt. J Infect 2015; 70:512-9.
28. Schroter M, Zollner B, Schafer P, et al. Quantitative detection of hepatitis C virus RNA by light cycler PCR and comparison with two different PCR assays. J Clin Microbiol 2001; 39:765-8.
29. Committee on Infectious Diseases, A.A.o.P. Hepatitis C virus. In: Pickering LK, ed. Red Book: 2012 Report of the Committee on Infectious Diseases. 29th edition ed. Elk Grove Village, IL: American Academy of Pediatrics; 2012: pp 391-5.
30. European Paediatric Hepatitis C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission of hepatitis C virus infection. J Infect Dis 2005; 192:1872-9.
31. Abdul Qawi K, Youssef A, Metwally MA, et al. Prospective study of prevalence and risk factors for hepatitis C in pregnant Egyptian women and its transmission to their infants. Croat Med J 2010; 51:219-28.
32. Hurtado CW, Golden-Mason L, Brocato M, et al. Innate immune function in placenta and cord blood of hepatitis C-seropositive motherinfant dyads. PLoS One 2010; 5:e12232.
33. Honegger JR, Kim S, Price AA, et al. Loss of immune escape mutations during persistent HCV infection in pregnancy enhances replication of vertically transmitted viruses. Nat Med 2013; 19:1529-33.
34. El-Kamary SS, Hashem M, Saleh DA, et al. Hepatitis C virus-specific cell-mediated immune responses in children born to mothers infected with hepatitis C virus. J Pediatr 2013; 162:148-54.
35. Ray SC, Arthur RR, Carella A, et al. Genetic epidemiology of hepatitis C virus throughout Egypt. J Infect Dis 2000; 182:698-707.
36. Tanaka Y, Agha S, Saudy N, et al. Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 2004; 58:191-5.